Toxicity management strategies for next-generation novel therapeutics in multiple myeloma

por Steinbach, Mary, Julian, Kelley, McClune, Brian, Sborov, Douglas W.
Publicado 2022

The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance

por Castillo, Jorge J., Callander, Natalie S., Baljevic, Muhamed, Sborov, Douglas W., Kumar, Shaji
Publicado 2021

Duo Shared Genomic Segment analysis identifies a genome-wide significant risk locus at 18q21.33 in myeloma pedigrees

por Griffin Waller, Rosalie, Madsen, Michael J., Gardner, John, Sborov, Douglas W., Camp, Nicola J.
Publicado 2021

Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide

por Trunk, Andrew D., Patel, Sagar S., Prchal, Josef T., Sborov, Douglas W., Zander, Axel R., Lee, Catherine J.
Publicado 2023

Deep Transcriptome Profiling of Multiple Myeloma Using Quantitative Phenotypes

por Griffin, Rosalie, Hanson, Heidi A., Avery, Brian J., Madsen, Michael J., Sborov, Douglas W., Camp, Nicola J.
Publicado 2023

Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies

por Fatoki, Raleigh Ayoolu, Koehn, Kelly, Kelkar, Amar, Al Hadidi, Samer, Mehra, Nikita, Mian, Hira, Landgren, Ola, Kazandjian, Dickran, Hoffman, James, Sborov, Douglas W., Mohyuddin, Ghulam Rehman
Publicado 2022

P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP

por Hydren, Jay R., Lin, Dee, Arturo Hurtado, Jorge, Sweeney, Nathan W., Wu, Bingcao, Gries, Katharine, Kim, Nina, Patel, Saurabh, Sborov, Douglas W., Berdeja, Jesus, Anderson, Larry D., Stephen Huo, Jinhai, Ahlstrom, Jennifer M.
Publicado 2023

Pharmacokinetic‐Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High‐Dose Melphalan for Autologous Stem Cell Transplant

por Cho, Yu Kyoung, Irby, Donald J., Li, Junan, Sborov, Douglas W., Mould, Diane R., Badawi, Mohamed, Dauki, Anees, Lamprecht, Misty, Rosko, Ashley E., Fernandez, Soledad, Hade, Erinn M., Hofmeister, Craig C., Poi, Ming, Phelps, Mitch A.
Publicado 2018

A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma

por Paul, Barry, Liedtke, Michaela, Khouri, Jack, Rifkin, Robert, Gandhi, Mitul D, Kin, Andrew, Levy, Moshe Y, Silbermann, Rebecca, Cottini, Francesca, Sborov, Douglas W, Sandhu, Irwindeep, Villarreal, Lyssa, Murphy, Michael, Gu, Lin, Chen, Ann, Rajakumaraswamy, Nishanthan, Usmani, Saad Z
Publicado 2023

Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide

por Canella, Alessandro, Nieves, Hector Cordero, Sborov, Douglas W., Cascione, Luciano, Radomska, Hanna S., Smith, Emily, Stiff, Andrew, Consiglio, Jessica, Caserta, Enrico, Rizzotto, Lara, Zanesi, Nicola, Stefano, Volinia, Kaur, Balveen, Mo, Xiaokui, Byrd, John C., Efebera, Yvonne A., Hofmeister, Craig C., Pichiorri, Flavia
Publicado 2023

HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide

por Canella, Alessandro, Nieves, Hector Cordero, Sborov, Douglas W., Cascione, Luciano, Radomska, Hanna S., Smith, Emily, Stiff, Andrew, Consiglio, Jessica, Caserta, Enrico, Rizzotto, Lara, Zanesi, Nicola, Stefano, Volinia, Kaur, Balveen, Mo, Xiaokui, Byrd, John C., Efebera, Yvonne A., Hofmeister, Craig C., Pichiorri, Flavia
Publicado 2015

Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes

por Waller, Rosalie Griffin, Klein, Robert J, Vijai, Joseph, McKay, James D, Clay-Gilmour, Alyssa, Wei, Xiaomu, Madsen, Michael J, Sborov, Douglas W, Curtin, Karen, Slager, Susan L, Offit, Kenneth, Vachon, Celine M, Lipkin, Steven M, Dumontet, Charles, Camp, Nicola J
Publicado 2021

IFITM3 regulates fibrinogen endocytosis and platelet reactivity in nonviral sepsis

por Campbell, Robert A., Manne, Bhanu Kanth, Banerjee, Meenakshi, Middleton, Elizabeth A., Ajanel, Abigail, Schwertz, Hansjorg, Denorme, Frederik, Stubben, Chris, Montenont, Emilie, Saperstein, Samantha, Page, Lauren, Tolley, Neal D., Lim, Diana L., Brown, Samuel M., Grissom, Colin K., Sborov, Douglas W., Krishnan, Anandi, Rondina, Matthew T.
Publicado 2022

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo

por Ghose, Jayeeta, Dona, Ada, Murtadha, Mariam, Gunes, Emine Gulsen, Caserta, Enrico, Yoo, Ji Young, Russell, Luke, Jaime-Ramirez, Alena Cristina, Barwick, Benjamin G., Gupta, Vikas A., Sanchez, James F., Sborov, Douglas W., Rosen, Steven T., Krishnan, Amrita, Boise, Lawrence H., Kaur, Balveen, Hofmeister, Craig C., Pichiorri, Flavia
Publicado 2021

Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study

por Sborov, Douglas W., Baljevic, Muhamed, Reeves, Brandi, Laubach, Jacob, Efebera, Yvonne A., Rodriguez, Cesar, Costa, Luciano J., Chari, Ajai, Silbermann, Rebecca, Holstein, Sarah A., Anderson, Larry D., Kaufman, Jonathan L., Shah, Nina, Pei, Huiling, Patel, Sharmila, Cortoos, Annelore, Bartlett, J. Blake, Vermeulen, Jessica, Lin, Thomas S., Voorhees, Peter M., Richardson, Paul G.
Publicado 2022

A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker

por Kelley, Kristen C., Grossman, Kenneth F., Brittain-Blankenship, Mary, Thorne, Kelli M., Akerley, Wallace L., Terrazas, Moises C., Kosak, Ken M., Boucher, Kenneth M., Buys, Saundra S., McGregor, Kimberly A., Werner, Theresa L., Agarwal, Neeraj, Weis, John R., Sharma, Sunil, Ward, John H., Kennedy, Thomas P., Sborov, Douglas W., Shami, Paul J.
Publicado 2021

P866: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): KARMMA-3 SUBGROUP ANALYSIS...

por Manier, Salomon, Rodríguez-Otero, Paula, Mateos, Maria-Victoria, Einsele, Hermann, Bahlis, Nizar J, Munshi, Nikhil, Ailawadhi, Sikander, Arnulf, Bertrand, Nooka, Ajay, Vij, Ravi, Weum Abrahamsen, Ingerid, Broijl, Annemiek, Jagannath, Sundar, Benjamin, Reuben, Gergis, Usama, Sborov, Douglas W., Iida, Shinsuke, Truppel-Hartmann, Anna, Yang, Zhihong, Piasecki, Julia, Felten, Jasper, Caia, Andrea, Cook, Mark, Baz, Rachid
Publicado 2023

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

por Ferreri, Christopher J., Hildebrandt, Michelle A. T., Hashmi, Hamza, Shune, Leyla O., McGuirk, Joseph P., Sborov, Douglas W., Wagner, Charlotte B., Kocoglu, M. Hakan, Rapoport, Aaron, Atrash, Shebli, Voorhees, Peter M., Khouri, Jack, Dima, Danai, Afrough, Aimaz, Kaur, Gurbakhash, Anderson, Larry D., Simmons, Gary, Davis, James A., Kalariya, Nilesh, Peres, Lauren C., Lin, Yi, Janakiram, Murali, Nadeem, Omar, Alsina, Melissa, Locke, Frederick L., Sidana, Surbhi, Hansen, Doris K., Patel, Krina K., Castaneda Puglianini, Omar Alexis
Publicado 2023